Baird Maintains Neutral on Healthcare Services Group, Raises Price Target to $14
Baird Maintains Neutral on Healthcare Services Group, Raises Price Target to $14
貝爾德維持對healthcare services group的中立評級，將目標價上調至14美元。
Baird analyst Andrew Wittmann maintains Healthcare Services Group (NASDAQ:HCSG) with a Neutral and raises the price target from $13 to $14.
貝爾德分析師安德魯·維特曼維持healthcare services group（納斯達克：HCSG）的中立評級，並將其目標價從13美元上調至14美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。